{"DataElement":{"publicId":"2900097","version":"1","preferredName":"Breast Carcinoma Biomarker Group Progesterone Receptor java.lang.Boolean","preferredDefinition":"(brest KAN-ser) Cancer that forms in tissues of the breast, usually the ducts (tubes that carry milk to the nipple) and lobules (glands that make milk). It occurs in both men and women, although male breast cancer is rare.:A variation in cellular or biochemical components or processes, structures, or functions that is objectively measurable in a biological system and that characterizes normal biologic processes, pathogenic processes, an organism's state of health or disease, likelihood of developing a disease, prognosis, or response to a particular therapeutic intervention. Biomarkers include but not limited to such phenotypic parameters as specific enzyme or hormone concentration, specific gene phenotype, presence or absence of biological substances.:Any number of entities (members) considered as a unit._Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of proge_Generic value domain for a primitive java datatype that is a Boolean value (true or false).","longName":"2899839v1.0:2178538v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2899839","version":"1","preferredName":"Breast Carcinoma Biomarker Group Progesterone Receptor","preferredDefinition":"(brest KAN-ser) Cancer that forms in tissues of the breast, usually the ducts (tubes that carry milk to the nipple) and lobules (glands that make milk). It occurs in both men and women, although male breast cancer is rare.:A variation in cellular or biochemical components or processes, structures, or functions that is objectively measurable in a biological system and that characterizes normal biologic processes, pathogenic processes, an organism's state of health or disease, likelihood of developing a disease, prognosis, or response to a particular therapeutic intervention. Biomarkers include but not limited to such phenotypic parameters as specific enzyme or hormone concentration, specific gene phenotype, presence or absence of biological substances.:Any number of entities (members) considered as a unit._Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of proge","longName":"2899671v1.0:2553961v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2899671","version":"1","preferredName":"Breast Carcinoma Biomarker Group","preferredDefinition":"(brest KAN-ser) Cancer that forms in tissues of the breast, usually the ducts (tubes that carry milk to the nipple) and lobules (glands that make milk). It occurs in both men and women, although male breast cancer is rare.:A variation in cellular or biochemical components or processes, structures, or functions that is objectively measurable in a biological system and that characterizes normal biologic processes, pathogenic processes, an organism's state of health or disease, likelihood of developing a disease, prognosis, or response to a particular therapeutic intervention. Biomarkers include but not limited to such phenotypic parameters as specific enzyme or hormone concentration, specific gene phenotype, presence or absence of biological substances.:Any number of entities (members) considered as a unit.","longName":"C4872:C16342:C43359","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Carcinoma","conceptCode":"C4872","definition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Biomarker","conceptCode":"C16342","definition":"A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Group","conceptCode":"C43359","definition":"Any number of entities (members) considered as a unit.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C028E6E-6BCB-82B6-E040-BB89AD430FCA","latestVersionIndicator":"Yes","beginDate":"2009-06-10","endDate":null,"createdBy":"UMLLOADER_IMAGEMINER","dateCreated":"2009-06-10","modifiedBy":"ONEDATA","dateModified":"2009-06-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2553961","version":"1","preferredName":"Progesterone Receptor","preferredDefinition":"Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of proge","longName":"C17075","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Progesterone Receptor","conceptCode":"C17075","definition":"Progesterone receptor (933 aa, ~99 kDa) is encoded by the human PGR gene. This protein is involved in the regulation of transcription.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"24980B97-241D-5A76-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-14","endDate":null,"createdBy":"UMLLOADER_CATRIP","dateCreated":"2006-12-14","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2222502","version":"1","preferredName":"UML DEFAULT CD","preferredDefinition":"Default Conceptual Domain for UML Loader","longName":"UML DEFAULT CD","context":"caCORE","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E53F3B-47A4-52D1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-04-29","modifiedBy":"DWARZEL","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C02A29B-871E-4258-E040-BB89AD432F81","latestVersionIndicator":"Yes","beginDate":"2009-06-10","endDate":null,"createdBy":"UMLLOADER_IMAGEMINER","dateCreated":"2009-06-10","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"1/1/11 Released as part of ImageMiner model cleanup.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2178538","version":"1","preferredName":"java.lang.Boolean","preferredDefinition":"Generic value domain for a primitive java datatype that is a Boolean value (true or false).","longName":"java.lang.Boolean","context":"caCORE","contextVersion":"1","type":"Non-enumerated","dataType":"java.lang.Boolean","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2178532","version":"1","preferredName":"Bioinformatics","preferredDefinition":".","longName":"BIOINFORMATICS","context":"caCORE","contextVersion":"1","origin":null,"workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"CD81DD3C-8FFA-28BA-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-12-02","endDate":"2020-10-14","createdBy":"SBREXT","dateCreated":"2003-12-02","modifiedBy":"TAYLORT","dateModified":"2020-10-14","changeDescription":"10.14.20 TL changed WFS from DRAFT NEW to RETIRED ARCHIVED and added an End Date in preparation of OneData.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2320047","version":"1","preferredName":"Indicator","preferredDefinition":"An event, entity or condition that typically characterizes a prescribed environment or situation. Indicators determine or aid in determining whether or not certain stated circumstances exist or criteria are satisfied. (On-line Medical Dictionary)","longName":"C25180","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indicator","conceptCode":"C25180","definition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"FC6EF0D8-521A-6865-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-25","modifiedBy":"ONEDATA","dateModified":"2005-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CD831153-DAB5-28B6-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-12-02","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-02","modifiedBy":"CURTIST","dateModified":"2007-12-05","changeDescription":"03/30/2006 - Updated defintion and datatype (previously Boolean).","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2899621","version":"1","longName":"ImageMiner","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2899635","version":"1","longName":"org.imageminer.domain.tma.dynamic","context":"NCIP"},{"publicId":"2899634","version":"1","longName":"TMAMiner","context":"NCIP"}]}],"AlternateNames":[{"name":"BreastCancerMolecularPanel01:progesteroneReceptor","type":"UML Class:UML Attr","context":"NCIP"},{"name":"org.imageminer.domain.tma.dynamic.BreastCancerMolecularPanel01.progesteroneReceptor","type":"UML Qualified Attr","context":"NCIP"}],"ReferenceDocuments":[{"name":"Data Element Breast Carcinoma Biomarker Group Progesterone Receptor java.lang.Boolean does not have Preferred Question Text","type":"Preferred Question Text","description":"Data Element Breast Carcinoma Biomarker Group Progesterone Receptor java.lang.Boolean does not have Preferred Question Text","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C02B779-AB1E-8D9D-E040-BB89AD43516D","latestVersionIndicator":"Yes","beginDate":"2009-06-10","endDate":null,"createdBy":"UMLLOADER_IMAGEMINER","dateCreated":"2009-06-10","modifiedBy":"CHILLIJ","dateModified":"2011-01-01","changeDescription":"1/1/11 Released as part of ImageMiner model cleanup","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}